Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure
Saved in:
| Published in: | Immunotherapy Advances |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301675034738691 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Immunotherapy Advances |
| description | |
| discipline_display | Allergology and Immunology |
| discipline_facet | Allergology and Immunology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:84515 |
| institution | FRELIP |
| journal_source_facet | Immunotherapy Advances |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure Allergology and Immunology General Allergology and Immunology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Allergology and Immunology General Allergology and Immunology Allergology and Immunology General Allergology and Immunology |
| subject_facet | Allergology and Immunology General Allergology and Immunology |
| title | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| title_auth | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| title_full | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| title_fullStr | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| title_full_unstemmed | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| title_short | PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| title_sort | pd-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposure |
| topic | Allergology and Immunology General Allergology and Immunology |
| url | https://academic.oup.com/immunotherapyadv/article/doi/10.1093/immadv/ltag004/8494224?rss=1 |